Banminth,
Pyrantel Tartrate,
Tartrate, Pyrantel,
PYRANTEL TARTRATE,
33401-94-4,
Pyrantel tartrate salt,
Banminth,
Pyrantel (+)-tartrate salt,
Pyrequan tartrate,
Pyrantel (tartrate),
Pyrantel hydrogen tartrate,
Pyrantel tartrate [USAN],
UNII-SC82VF0480,
C11H14N2S.C4H6O6,
EINECS 251-501-8,
CP 10423-18,
SC82VF0480,
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (E)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1),
Pyrantel tartrate (USAN),
(E)-1,4,5,6-Tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine tartrate (1:1),
DSSTox_CID_28784,
DSSTox_RID_83053,
DSSTox_GSID_48858,
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)-, (E)-, tartrate (1:1),
Banminth 48,
NCGC00017103-02,
Banminth (TN),
(2R,3R)-2,3-dihydroxybutanedioic acid; 1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine,
CAS-33401-94-4,
AC1O5HEX,
Prestwick3_000212,
AC1Q59OS,
BSPBio_000223,
SCHEMBL536109,
BPBio1_000247,
CHEMBL2105309,
DTXSID4048858,
HMS2095L05,
HMS3712L05,
Tox21_113347,
3987AH,
AKOS016014952,
Tox21_113347_1,
CCG-220212,
CS-3870,
NCGC00174007-04,
HY-12641,
LS-135583,
ST24031576,
CP-10,423-18,
D05657,
SR-01000872648,
SR-01000872648-1,
Pyrantel tartrate, United States Pharmacopeia (USP) Reference Standard,
(E)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine (2R,3R)-2,3-dihydroxysuccinate,
Tartrate, Pyrantel,
PYRANTELTARTRATESALT,
CID6434144,
C11-H14-N2-S.C4-H6-O6,
D011717,
1-Methyl-2-(2-[2-thienyl]ethenyl)-1,4,5,6-tetrahydropyrimidine,
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]-,(E)-, tartrate (1:1),
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl- 2-[(1E)-2-(2-thienyl)ethenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]-, (E)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1),